{"transactions":[{"id":2314930,"issuer":{"id":15495,"kind":"organization","name":"Apria, Inc.","symbol":"APR"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"LTIP Units","published_at":"2022-03-29T16:31:08.000Z","date":"2022-03-29","kind":"disposition_to_issuer","acquired":false,"shares":20740,"price":37.5,"value":777750.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents a contingent right to receive one share of the Issuer's Common Stock payable in Common Stock, cash or a combination thereof at the discretion of the Issuer's Compensation Committee."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 29, 2022, Owens & Minor, Inc. (\"Owens & Minor\") acquired the Issuer pursuant to a certain Agreement and Plan of Merger, dated as of January 7, 2022 (the \"Merger Agreement\"), by and among the Issuer, Owens & Minor and StoneOak Merger Sub Inc., an indirect, wholly owned subsidiary of Owens & Minor (\"Merger Sub\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the \"Merger\") with the Issuer surviving the Merger as an indirect, wholly owned subsidiary of Owens & Minor. At the effective time of the Merger, each issued and outstanding share of the Issuer's Common Stock (other than certain excluded shares) automatically converted into the right to receive $37.50 per share in cash (the \"Merger Consideration\"), without interest and subject to applicable withholding tax."},{"field":"kind","element":"transactionCoding","label":"F5","text":"In connection with the Merger, certain long-term incentive plan units (\"LTIP\") were vested and cancelled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the number of shares of Common Stock subject to such LTIP immediately prior to the effective time of the Merger, multiplied by the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"In connection with the Merger, certain long-term incentive plan units (\"LTIP\") were vested and cancelled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the number of shares of Common Stock subject to such LTIP immediately prior to the effective time of the Merger, multiplied by the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Represents LTIP awards granted in 2020 which were originally scheduled to vest in equal quarterly installments beginning on March 31, 2020, subject to the satisfaction of certain performance criteria as determined at the end of the three year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Represents LTIP awards granted in 2020 which were originally scheduled to vest in equal quarterly installments beginning on March 31, 2020, subject to the satisfaction of certain performance criteria as determined at the end of the three year performance period."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":20740},"source":{"system":"sec-edgar","filing":"0000899243-22-012664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000089924322012664/doc4.xml","form_type":"4"}},{"id":2314929,"issuer":{"id":15495,"kind":"organization","name":"Apria, Inc.","symbol":"APR"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"LTIP Units","published_at":"2022-03-29T16:31:08.000Z","date":"2022-03-29","kind":"grant","acquired":true,"shares":20740,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents a contingent right to receive one share of the Issuer's Common Stock payable in Common Stock, cash or a combination thereof at the discretion of the Issuer's Compensation Committee."},{"field":"kind","element":"transactionCoding","label":"F5","text":"In connection with the Merger, certain long-term incentive plan units (\"LTIP\") were vested and cancelled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the number of shares of Common Stock subject to such LTIP immediately prior to the effective time of the Merger, multiplied by the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Represents LTIP awards granted in 2020 which were originally scheduled to vest in equal quarterly installments beginning on March 31, 2020, subject to the satisfaction of certain performance criteria as determined at the end of the three year performance period."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Represents LTIP awards granted in 2020 which were originally scheduled to vest in equal quarterly installments beginning on March 31, 2020, subject to the satisfaction of certain performance criteria as determined at the end of the three year performance period."}],"balance_after":20740,"derivative":{"underlying":"Common Stock","underlying_shares":20740},"source":{"system":"sec-edgar","filing":"0000899243-22-012664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000089924322012664/doc4.xml","form_type":"4"}},{"id":2314928,"issuer":{"id":15495,"kind":"organization","name":"Apria, Inc.","symbol":"APR"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2022-03-29T16:31:08.000Z","date":"2022-03-29","kind":"disposition_to_issuer","acquired":false,"shares":10370,"price":37.5,"value":388875.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Represents a contingent right to receive one share of the Issuer's Common Stock payable in Common Stock, cash or a combination thereof at the discretion of the Issuer's Compensation Committee."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On March 29, 2022, Owens & Minor, Inc. (\"Owens & Minor\") acquired the Issuer pursuant to a certain Agreement and Plan of Merger, dated as of January 7, 2022 (the \"Merger Agreement\"), by and among the Issuer, Owens & Minor and StoneOak Merger Sub Inc., an indirect, wholly owned subsidiary of Owens & Minor (\"Merger Sub\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer (the \"Merger\") with the Issuer surviving the Merger as an indirect, wholly owned subsidiary of Owens & Minor. At the effective time of the Merger, each issued and outstanding share of the Issuer's Common Stock (other than certain excluded shares) automatically converted into the right to receive $37.50 per share in cash (the \"Merger Consideration\"), without interest and subject to applicable withholding tax."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Pursuant to the Merger Agreement, each restricted stock unit (\"RSU\") became fully vested and cancelled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the number of shares of Common Stock subject to such RSU, immediately prior to the effective time of the Merger, multiplied by the Merger Consideration."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, each restricted stock unit (\"RSU\") became fully vested and cancelled and entitled the holder to receive an amount of cash, without interest and subject to deduction for any required tax withholding, equal to the number of shares of Common Stock subject to such RSU, immediately prior to the effective time of the Merger, multiplied by the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents RSUs granted in 2021, which were originally scheduled to vest in three equal annual installments beginning on June 10, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents RSUs granted in 2021, which were originally scheduled to vest in three equal annual installments beginning on June 10, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10370},"source":{"system":"sec-edgar","filing":"0000899243-22-012664","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000089924322012664/doc4.xml","form_type":"4"}},{"id":2669661,"issuer":{"id":15495,"kind":"organization","name":"Apria, Inc.","symbol":"APR"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2021-06-14T19:38:56.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":10370,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer (\"Common Stock\"). The restricted stock units will be settled in either Common Stock or cash (or a combination thereof) at the discretion of the Issuer's compensation committee."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on June 10, 2022, subject to the Reporting Person's continued employment on the applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on June 10, 2022, subject to the Reporting Person's continued employment on the applicable vesting date."}],"balance_after":10370,"derivative":{"underlying":"Common Stock","underlying_shares":10370},"source":{"system":"sec-edgar","filing":"0000899243-21-023690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000089924321023690/doc4.xml","form_type":"4"}},{"id":2811386,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-03T18:52:35.000Z","date":"2021-03-02","kind":"tax_withholding","acquired":false,"shares":880,"price":32.34,"value":28459.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan."}],"balance_after":55588,"source":{"system":"sec-edgar","filing":"0000950138-21-000178","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000095013821000178/edgar.xml","form_type":"4"}},{"id":2811385,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-03-03T18:52:35.000Z","date":"2021-03-01","kind":"tax_withholding","acquired":false,"shares":799,"price":33.65,"value":26886.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan."}],"balance_after":56468,"source":{"system":"sec-edgar","filing":"0000950138-21-000178","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000095013821000178/edgar.xml","form_type":"4"}},{"id":2835026,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-24T17:17:47.000Z","date":"2021-02-22","kind":"tax_withholding","acquired":false,"shares":6533,"price":30.58,"value":199779.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan."}],"balance_after":57267,"source":{"system":"sec-edgar","filing":"0000950138-21-000143","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000095013821000143/edgar.xml","form_type":"4"}},{"id":2835025,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2021-02-24T17:17:47.000Z","date":"2021-02-22","kind":"grant","acquired":true,"shares":21663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Vesting of performance-based restricted stock units granted under the 2018 Elanco Stock Plan."}],"balance_after":63800,"source":{"system":"sec-edgar","filing":"0000950138-21-000143","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000095013821000143/edgar.xml","form_type":"4"}},{"id":3230691,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-03-03T17:32:44.000Z","date":"2020-03-02","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 2, 2020, one-third vesting on March 2, 2021, one-third vesting on March 2, 2022, and the remaining vesting on March 2, 2023."}],"balance_after":42137,"source":{"system":"sec-edgar","filing":"0000950138-20-000120","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000095013820000120/edgar.xml","form_type":"4"}},{"id":3230690,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2020-03-03T17:32:44.000Z","date":"2020-03-01","kind":"tax_withholding","acquired":false,"shares":799,"price":27.4,"value":21892.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the 2018 Elanco Stock Plan."}],"balance_after":33137,"source":{"system":"sec-edgar","filing":"0000950138-20-000120","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000095013820000120/edgar.xml","form_type":"4"}},{"id":3429003,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-08-26T07:46:32.000Z","date":"2019-08-22","kind":"purchase","acquired":true,"shares":11030,"price":26.646,"value":293905.38,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.65 to $26.635, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price."}],"balance_after":33936,"source":{"system":"sec-edgar","filing":"0000950138-19-000470","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000095013819000470/edgar.xml","form_type":"4"}},{"id":3610577,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2019-03-05T17:42:03.000Z","date":"2019-03-01","kind":"grant","acquired":true,"shares":8181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on March 1, 2019, one-third vesting on March 1, 2020, one-third vesting on March 1, 2021, and the remaining vesting on March 1, 2022."}],"balance_after":22906,"source":{"system":"sec-edgar","filing":"0000950138-19-000110","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000095013819000110/edgar.xml","form_type":"4"}},{"id":3784685,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Non-Qualified Stock Option (Right-to-Buy)","published_at":"2018-10-23T18:11:03.000Z","date":"2018-10-20","kind":"grant","acquired":true,"shares":29383,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Grant of stock option pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant of stock option pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021."}],"balance_after":29383,"derivative":{"exercise_price":31.61,"expiration_date":"2028-10-20","underlying":"Elanco Animal Health Inc. Common Stock","underlying_shares":29383},"source":{"system":"sec-edgar","filing":"0000950138-18-000566","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000095013818000566/edgar.xml","form_type":"4"}},{"id":3784684,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-10-23T18:11:03.000Z","date":"2018-10-20","kind":"grant","acquired":true,"shares":9725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units pursuant to the 2018 Elanco Stock Plan on October 20, 2018, vesting on October 20, 2021."}],"balance_after":14725,"source":{"system":"sec-edgar","filing":"0000950138-18-000566","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000095013818000566/edgar.xml","form_type":"4"}},{"id":3807054,"issuer":{"id":3457,"kind":"organization","name":"Elanco Animal Health Inc","symbol":"ELAN"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-09-26T16:14:35.000Z","date":"2018-09-24","kind":"purchase","acquired":true,"shares":5000,"price":24,"value":120000.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001140361-18-039142","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1596081/000114036118039142/form4.xml","form_type":"4"}},{"id":4105046,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2018-01-06T00:50:56.000Z","date":"2018-01-03","kind":"tax_withholding","acquired":false,"shares":467,"price":23.51,"value":10979.17,"ownership":{"direct":true},"balance_after":16342,"source":{"system":"sec-edgar","filing":"0000950138-18-000059","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013818000059/edgar.xml","form_type":"4"}},{"id":4164977,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2017-11-13T21:10:41.000Z","date":"2017-11-09","kind":"purchase","acquired":true,"shares":7900,"price":20.7986,"value":164308.94,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 530 shares acquired between January 1, 2017 and September 30, 2017 under the Mallinckrodt employee stock purchase plan."}],"balance_after":16809,"source":{"system":"sec-edgar","filing":"0000950138-17-000748","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000748/edgar.xml","form_type":"4"}},{"id":4359896,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2017-04-04T20:10:35.000Z","date":"2017-04-01","kind":"tax_withholding","acquired":false,"shares":260,"price":44.57,"value":11588.2,"ownership":{"direct":true},"balance_after":8379,"source":{"system":"sec-edgar","filing":"0000950138-17-000355","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000355/edgar.xml","form_type":"4"}},{"id":4394369,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2017-03-08T13:46:19.000Z","date":"2017-03-07","kind":"purchase","acquired":true,"shares":290,"price":50.35,"value":14601.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 406 shares acquired between April 6, 2016 and December 31, 2016 under the Mallinckrodt employee stock purchase plan."}],"balance_after":8639,"source":{"system":"sec-edgar","filing":"0000950138-17-000290","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000290/edgar.xml","form_type":"4"}},{"id":4501493,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Share Options (Right to Buy)","published_at":"2017-01-05T01:59:17.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":27151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in four equal annual installments beginning January 3, 2018."}],"balance_after":27151,"derivative":{"exercise_price":51.73,"exercise_date":"2018-01-03","expiration_date":"2027-01-03","underlying":"Ordinary Shares","underlying_shares":27151},"source":{"system":"sec-edgar","filing":"0000950138-17-000016","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000016/edgar.xml","form_type":"4"}},{"id":4501492,"issuer":{"id":28960,"kind":"organization","name":"Keenova Therapeutics plc","symbol":"NONE"},"owners":[{"id":128670,"kind":"person","name":"Hicks Michael-Bryant","position":1,"cik":"0001596081","reported_name":"Hicks Michael-Bryant","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2017-01-05T01:59:17.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":4833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning January 3, 2018."}],"balance_after":7943,"source":{"system":"sec-edgar","filing":"0000950138-17-000016","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1567892/000095013817000016/edgar.xml","form_type":"4"}}]}